Hjælpemiddel Konsulenten ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  14.3% 11.4% 12.8% 7.0% 40.2%  
Credit score (0-100)  16 22 18 33 0  
Credit rating  BB BB BB BBB C  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  467 746 1,163 1,287 607  
EBITDA  51.1 205 97.6 247 -488  
EBIT  33.7 170 62.4 221 -650  
Pre-tax profit (PTP)  26.5 156.6 28.2 186.3 -690.6  
Net earnings  26.5 184.6 6.0 135.7 -581.2  
Pre-tax profit without non-rec. items  26.5 157 28.2 186 -691  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  0.0 190 172 180 17.2  
Shareholders equity total  -319 -134 -129 58.7 -523  
Interest-bearing liabilities  0.0 208 41.5 64.0 98.1  
Balance sheet total (assets)  680 878 1,232 1,081 794  

Net Debt  -315 44.9 -447 -38.6 48.7  
 
See the entire balance sheet

Volume 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  467 746 1,163 1,287 607  
Gross profit growth  13.9% 59.7% 55.8% 10.7% -52.9%  
Employees  1 0 0 0 0  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  680 878 1,232 1,081 794  
Balance sheet change%  243.3% 29.1% 40.3% -12.2% -26.6%  
Added value  51.1 204.8 97.6 256.6 -487.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -35 137 -70 -25 -326  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  7.2% 22.7% 5.4% 17.2% -107.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.6% 17.1% 5.4% 18.4% -54.2%  
ROI %  95.1% 165.5% 51.5% 251.4% -552.2%  
ROE %  6.0% 23.7% 0.6% 21.0% -136.4%  

Solidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  -46.2% -14.4% -9.5% 5.4% -39.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -616.5% 21.9% -458.0% -15.6% -10.0%  
Gearing %  0.0% -155.0% -32.3% 109.1% -18.7%  
Net interest  0 0 0 0 0  
Financing costs %  24.4% 14.8% 28.8% 73.2% 49.7%  

Liquidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.8 0.6 0.7 0.3 0.3  
Current Ratio  0.6 0.7 0.8 0.9 0.6  
Cash and cash equivalent  315.1 162.9 488.6 102.6 49.4  

Capital use efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -361.2 -254.8 -334.5 -146.0 -561.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  51 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  51 0 0 0 0  
EBIT / employee  34 0 0 0 0  
Net earnings / employee  27 0 0 0 0